Delivery Order SPE2DR25D1053-SPE2DR26FV358
- Not listed
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency on August 14, 2025, with an ultimate completion date of September 5, 2025. The delivery order is for XDEMVY 0.25% Drop 10ML and utilizes firm fixed price pricing with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency (DLA) for 0.25% XDEMVY drop in a 10 milliliter formulation, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 5, 2025, and scheduled for completion by September 26, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,184.60 for XDEMVY 0.25% Drop 10ML pharmaceutical products. This is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product, with an ultimate completion date of October 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,184.60. The contract is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, and was competitively awarded without set-aside designation. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical products. This firm fixed price, competitively awarded delivery order is scheduled for completion by December 8, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML on December 29, 2025, with an ultimate completion date of January 21, 2026. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV358Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 8, 2026, for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This competitively awarded, non-set-aside contract has a ceiling value of $1,184.60 and is scheduled for completion by January 30, 2026. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with firm fixed-price terms. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen holds a critical position in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order represents a routine procurement transaction under the established IDC framework, enabling rapid fulfillment of specific pharmaceutical requirements across the Defense Health Agency and other authorized federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |